Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
6–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent
General good health other than seasonal allergic rhinitis
Positive standard skin prick test
You may not be if
Pregnancy, nursing, or plans to become pregnant or donate gametes for in vitro fertilization
Participation in any investigational drug trial within the 30 days preceding the Screening Visit
A known hypersensitivity to any corticosteroid or any of the ingredients in the study drug formulation
Plans to travel outside the study area (the known pollen area for the investigative site) for 24 hours or more during the final 7 days of the baseline period
Plans to travel outside the study area (the known pollen area for the investigative site) for more than 2 consecutive days OR more than 3 days total during the treatment period
Use of any prohibited concomitant medications
Non-vaccinated exposure to or active infection with chickenpox or measles within the 21 days preceding the Screening Visit
Use of antiepileptic drugs for epilepsy within 30 days of the Screening Visit
Study participation by more than one patient from the same household
Clareo Health | Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
